Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, β-Secretase-cleaved Fragments, and Amyloid β-Peptide via an Isoprenoid-dependent Mechanism
Open Access
- 1 May 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (19) , 18755-18770
- https://doi.org/10.1074/jbc.m413895200
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Evidence That Assembly of an Active γ-Secretase Complex Occurs in the Early Compartments of the Secretory PathwayJournal of Biological Chemistry, 2004
- RETRACTED: Statin blocks Rho/Rho-kinase signalling and disrupts the actin cytoskeleton: relationship to enhancement of LPS-mediated nitric oxide synthesis in vascular smooth muscle cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndromeNeurobiology of Aging, 2004
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsThe Journal of cell biology, 2003
- The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formationNature Neuroscience, 2001
- Elevated Low-Density Lipoprotein in Alzheimer's Disease Correlates with Brain Aβ 1–42 LevelsBiochemical and Biophysical Research Communications, 1998
- Differential Effects of a Rab6 Mutant on Secretory Versus Amyloidogenic Processing of Alzheimer's β-Amyloid Precursor ProteinJournal of Biological Chemistry, 1996
- Plasma lipids and cholesterol esterification in Alzheimer's diseaseMechanisms of Ageing and Development, 1994
- Regulation of the mevalonate pathwayNature, 1990
- Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid proteinBiochemical and Biophysical Research Communications, 1984